Veradermics MANE
NYSE MANE
$132.21 +5.11 (+4.02%)
As of: Oct 21, 2026 · 9:58 AM EDT

Veradermics (MANE) Common Stock Issued (2025 - 2026)

Updated

Analysis

Veradermics (MANE) Common Stock Issued (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Issued (Qtr)
1 Eli Lilly 1,136.25 Bn 1,104.84 Bn 19.71 Bn -
2 Johnson & Johnson 615.56 Bn 534.09 Bn 17.26 Bn 359.00 Mn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn -
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn 43.00 Mn
5 Novartis Ag 298.15 Bn 262.14 Bn 11.24 Bn -
6 Astrazeneca 262.32 Bn 236.01 Bn 12.86 Bn 6.00 Mn
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn -
8 Gilead Sciences 191.30 Bn 165.50 Bn 6.22 Bn 9.00 Mn
9 Pfizer 170.97 Bn 117.62 Bn 10.94 Bn -
10 Veradermics 5.34 Bn 3.94 Bn - 442.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 442.70 Mn
Mar 31, 2026 269.11 Mn
Jun 30, 2025 129,000.00
API Access

Veradermics Common Stock Issued API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-stock-issued&ticker=MANE&period=max&api_key=YOUR_API_KEY